M87.1
Osteonecrosis due to drugs
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
Osteonecrosis due to drugs, classified under ICD-10 code M87.1, is a condition where bone tissue dies because of diminished blood flow, associated specifically with drug use. This condition can affect various bones in the body, leading to pain, reduced mobility, and other health complications. It is important for individuals on certain medications to be aware of the potential risks and symptoms associated with this condition.
Causes & Symptoms
Clinical Causes: Prolonged or high-dose use of corticosteroids Use of certain immunosuppressive drugs Intravenous bisphosphonate therapy Use of alcohol in conjunction with medications Combination of medications that impair blood flow to bones
Key Symptoms: Joint pain, often worsening over time Limited range of motion in affected joints Swelling or tenderness around the joint Pain that may disturb sleep or daily activities Possible joint collapse in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history, physical examination, and imaging studies. Magnetic resonance imaging (MRI) is particularly useful in early detection, revealing changes in bone marrow and blood flow before structural damage occurs. X-rays may show bone collapse or joint destruction in later stages. Blood tests might also be conducted to rule out other causes of joint pain.
Treatment Protocols: Management of osteonecrosis due to drugs depends on the severity and the affected area. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is M87.1 a billable ICD-10 code?
Yes, M87.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M87.1?
Clinical documentation must specify the nature of Osteonecrosis due to drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
